A $700 blood test promises to detect 50 different kinds of cancer. The results come with major caveats. [Business Insider]
Exact Sciences Corporation (EXAS)
Last exact sciences corporation earnings: 2/11 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.exactsciences.com/investor-relations/default.aspx
Company Research
Source: Business Insider
This story is available exclusively to Business Insider subscribers. Become an Insider and start reading now. Have an account? Log in Grail's Galleri test promises to detect cancer signals in your blood. It's good at finding advanced cancers, but can miss early-stage cases. Telehealth company Hims & Hers is offering Galleri at a $250 discount, but there's a catch. A Super Bowl ad airing this weekend by telehealth company Hims & Hers pokes fun at "rich people" and their obsession with living longer. "All that money doesn't just buy more stuff, it buys more time," the ad voiceover says, a gentle nod toward rich and powerful longevity enthusiasts such as Sam Altman , Jeff Bezos, and Bryan Johnson Yet the commercial also argues our "wealth gap is a health gap" and that everyday people should have the same access to high-end biological testing that elite concierge medicine services offer the rich, such as regular blood draws , GLP-1 drugs, and yes, peptides. The latest addit
Show less
Read more
Impact Snapshot
Event Time:
EXAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXAS alerts
High impacting Exact Sciences Corporation news events
Weekly update
A roundup of the hottest topics
EXAS
News
- Halper Sadeh LLC is Investigating Whether CTRA, EXAS, NFBK are Obtaining Fair Deals for their ShareholdersGlobeNewswire
- $HAREHOLDER ALERT: The M&A Class Action Firm Encourages $hareholders to Act Before the Vote—EXAS, SNDA, FSUN, and TBNGlobeNewswire
- Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences' '746 Patent [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests [Yahoo! Finance]Yahoo! Finance
- Exact Sciences Applauds Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection TestsBusiness Wire
EXAS
Earnings
- 11/3/25 - Beat
EXAS
Sec Filings
- 1/30/26 - Form DEFA14A
- 1/23/26 - Form DEFA14A
- 1/9/26 - Form DEFM14A
- EXAS's page on the SEC website